Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas

Alós Cortés, Juan Ignacio; Andreu Domingo, Antonia; Arribas Mir, Lorenzo; Cabero Roura, Luis; Cueto López , Marina de; López Sastre, José; Melchor Marcos, Juan Carlos; Puertas Prieto, Alberto; Rosa Fraile, Manuel de la; Sanchez Pérez, María José; Torrejon Cardoso, Rafael; Salcedo Abizanda, Salvador; Sánchez Luna, Manuel.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 21(8): 417-423, oct. 2003.
Artigo em Es | IBECS (Espanha) | ID: ibc-25003

Documentos relacionados

  1. Latency Antibiotics in Preterm Prelabor Rupture of Membranes: A Comparison of Azithromycin Regimens.
  2. Azithromycin treatment for short cervix with or without amniotic fluid sludge: A matched cohort study.
  3. Antibiotic treatment reduces the intensity of intraamniotic inflammation in pregnancies with idiopathic vaginal bleeding in the second trimester of pregnancy.
  4. Maternal morbidity after preterm premature rupture of membranes at <24 weeks' gestation.
  5. Wearable sensors for prediction of intraamniotic infection in women with preterm premature rupture of membranes: a prospective proof of principle study.
  6. Alloscardovia omnicolens emerging presence in premature rupture of membranes.
  7. Latency Period after Preterm Premature Rupture of Membranes: Singletons versus Twins.
  8. Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis.
  9. Individualized treatment of preterm premature rupture of membranes to prolong the latency period, reduce the rate of preterm birth, and improve neonatal outcomes.
  10. Clinical Chorioamnionitis and Neurodevelopment at 5 Years of Age in Children Born Preterm: The EPIPAGE-2 Cohort Study.